More importantly, over‐expression of miR‐590 could decrease N‐cadherin and Vimentin protein levels but increase the E‐cadherin level, suggesting miR‐590 acts as a tumor suppressor that restrains the EMT process in ESCC (Figure 3F). The gene discussed is CDH2; the disease is esophageal squamous cell carcinoma.